Expand RPRX Menu
RPRX MENU

RPRX Latest Press Releases

-- April 21, 2026 --

Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation Globe Newswire 1:00 PM

-- April 17, 2026 --

Royalty Pharma Declares Second Quarter 2026 Dividend Globe Newswire 8:30 AM

-- April 15, 2026 --

Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 Globe Newswire 4:15 PM

-- March 30, 2026 --

Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases Globe Newswire 7:15 AM

-- March 23, 2026 --

Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence Globe Newswire 7:15 AM

-- March 17, 2026 --

Royalty Pharma Announces Expansion of Leadership Team Globe Newswire 4:01 PM

-- March 2, 2026 --

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform Globe Newswire 7:00 AM
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing Globe Newswire 6:10 AM
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing Globe Newswire 6:01 AM

-- February 26, 2026 --

Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference Globe Newswire 4:15 PM

-- February 11, 2026 --

Royalty Pharma Reports Q4 and Full Year 2025 Results Globe Newswire 7:00 AM

-- January 20, 2026 --

Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 Globe Newswire 4:15 PM

-- January 12, 2026 --

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:15 AM

-- January 11, 2026 --

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo Globe Newswire 5:15 PM
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo Globe Newswire 5:00 PM

-- January 9, 2026 --

Royalty Pharma Announces Dividend Increase Globe Newswire 8:30 AM

-- December 29, 2025 --

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones Globe Newswire 4:40 PM

-- December 16, 2025 --

Royalty Pharma Acquires Royalty Interest in Nuvalent's Neladalkib and Zidesamtinib for Up to $315 Million Globe Newswire 7:15 AM

-- December 12, 2025 --

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PRNewswire 10:48 AM

-- December 4, 2025 --

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement Globe Newswire 7:10 AM
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement Globe Newswire 7:00 AM

-- November 26, 2025 --

Royalty Pharma to Present at Upcoming Investor Conferences Globe Newswire 8:15 AM
Market Data Delayed 15 Minutes